Topical Ascorbic Acid Mesotherapy with Microneedling versus Topical Tranexamic Acid Mesotherapy with Microneedling for Melasma: A Therapeutic Comparative Study

Soleen Saman  Hasan; Mohammed Yousif  Saeed; Harem Ahmed  Hamakarim

doi:10.56056/amj.2024.287

Authors

Soleen Saman Hasan Dermatological Teaching Center, Sulaimani Directorate of Health, Sulaimaniyah, Iraq
Mohammed Yousif Saeed Assistant Professor in Skin Diseases, Department of Medicine, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq
Harem Ahmed Hamakarim Shahid Jabar Dermatological Teaching Center Sulaimani Directorate of Health, Sulaimaniyah, Iraq

DOI:

https://doi.org/10.56056/amj.2024.287

Keywords:

Advanced technique, Acid mesotherapy, Microneedling, Melasma

Abstract

Background & objectives: Melasma is a common skin hyperpigmentation syndrome that frequently includes reproductive-aged females, and numerous therapies with various consequences have been suggested. Thus, the objective was to compare the microneedling and mesotherapeutic effects of ascorbic acid versus tranexamic acid for melasma treatments.

Methods: This interventional therapeutic prospective study was conducted on 40 patients with melasma at Khabat Consultation Center for Skin Diseases, Sulaimaniyah, Iraq, from March 2022 to August 2022. Sociodemographic data of patients were collected together with a family history of melasma using a well-designed questionnaire. Half of the patients were treated with ascorbic acid, while the rest were treated with tranexamic acid using a derma pen.

Results: Highly significant reduction of MASI score were seen before and after treatment (p<0.001) were seen in mean scores before and after treatments for both types of treatments (ascorbic acid and tranexamic acid). Moreover, ascorbic acid results in the highest mean score reduction in skin type III (p=0.746), while tranexamic acid results in the highest mean score in skin type IV (p<0.05). Furthermore, the dermal melasma recorded the highest mean score, and the lowest level was observed in the epidermal melasma for both ascorbic acid and tranexamic acid groups. No significant difference was found between both studied groups in sociodemographic data and other studied variables (family history, skin type, previous treatment, and duration of melasma).

Conclusions: Both types of therapy mesotherapy was effective in treating melasma; however, their potencies varied on different skin types and according to melasma types.

Downloads

Download data is not yet available.

References

Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65(4):699-14.

Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014; 89:771-82.

Artzi O, Horovitz T, Bar?Ilan E, Shehadeh W, Koren A, Zusmanovitch L et al. The pathogenesis of melasma and implications for treatment. J Cosmet Dermatol. 2021;20(11):3432-45.

Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. Anais brasileiros de dermatologia. 2014;89:771-82.

Victor FC, Gelber J, Rao B. Melasma: a review. J Cut Med Surg: Incorp Med Surg Dermatol. 2004;8:97-02.

McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21(2):173-225.

Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther. 2017;7(3):305-18.

Pazyar N, Molavi SN, Hosseinpour P, Hadibarhaghtalab M, Parvar SY, Dezfuly MB. Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: A split?face comparative trial. Health Sci Rep. 2022;5(2): e537.

Polat Y, Saraç G. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment. Dermatol Ther. 2022: e15499.

Ravetti S, Clemente C, Brignone S, Hergert L, Allemandi D, Palma S. Ascorbic acid in skin health. Cosmet. 2019;6(4):58.

Sepaskhah M, Karimi F, Bagheri Z, Kasraee B. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma. J Cosmet Dermatol. 2022;21(7):2871-8.

Yang J, Zeng J, Lu J. Mechanisms of ultraviolet?induced melasma formation: A review. J Dermatol. 2022.

Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(1):78-83. e2.

Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27(8):1035-9.

Lindgren AL, Austin AH, Welsh KM. The use of tranexamic acid to prevent and treat post-inflammatory hyperpigmentation. J Drugs Dermatol. 2021;20(3):344-5.

Zhao H, Li M, Zhang X, Li L, Yan Y, Wang B. Comparing the efficacy of Myjet assisted tranexamic acid and vitamin C in treating melasma: A split face controlled trial. J Cosmet Dermatol. 2020;19(1):47-54.

Tahoun AI, Mostafa WZ, Amer MA. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study. J Dermatol Treat. 2022;33(3):1623-9.

Balevi A, Ustuner P, Özdemir M. Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: a comparative study. J Cosmet Laser Ther. 2017;19(5):294-9.

Dayal S, Sahu P, Yadav M, Jain VK. Clinical efficacy and safety on combining 20% trichloroacetic acid peel with topical 5% ascorbic acid for melasma. JCDR 2017;11(9): WC08.

Kumawat K, Bhatia K, Bhatia J, Kataria R, Namdeo C, Sarin A. Comparative study of efficacy of intradermal tranexamic acid microinjections versus intradermal glutathione microinjections for treatment of facial melasma. Pigment Int. 2022;9(1):46-50.

Ismail ESA, Patsatsi A, Abd el?Maged WM, Nada EE. Efficacy of microneedling with topical vitamin C in the treatment of melasma. J Cosmet Dermatol. 2019;18(5):1342-7.

Aamir S, Naseem R. Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study. J Pak Assoc Dermatol. 2014;24(3):198-203.